Biologic Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biologic therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biologic Therapies Today - Breaking & Trending Today

Vivtex Enters Research Collaboration with Astellas Pharma

Cambridge, MA, USA and Zurich, Switzerland – 23rd January 2024. Vivtex Corporation (“Vivtex” or “the Company”), a biotech company aiming to transform the development of oral biologic therapies for major diseases, announces that it has entered a research collaboration with Astellas Pharma Inc. (“Astellas”), a global pharmaceutical company. The collaboration is focused on the evaluation of Vivtex’s unique and proprietary GI-ORIS™ (“Gut on a chip” and AI) screening and formulation platform technolo ....

United Kingdom , United States , Switzerland General , Astellas Pharma , Maureen Deehan , Astellas Pharma Inc , Vivtex Corporation , Harvard University , Nature Biomedical Engineering , Robert Langer , Giovanni Traverso , Astellas Pharma Inc , Biologic Therapies , Biologic Drugs , Maureen Deehan , Research Collaboration , Nature Biomedical Engineering ,

Atopic Dermatitis Drugs Market Size to Surpass USD 28.2 billion by 2031, at a CAGR of 8.9%

A rise in demand for biologics, a surge in healthcare expenditure, and a rise in new product approvals are anticipated to boost the atopic dermatitis drugs market in the forecast period.Wilmington, Delaware, United States, Oct. 16, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. -The global atopic dermatitis drugs market is likely to develop at an 8.9% CAGR from 2023 to 2031, reaching US$ 28.2 billion by 2031. Atopic dermatitis, a common and chronic inflammatory skin disease, affects ....

United States , Asia Pacific , Eli Lilly , Nikhil Sawlani , European Commission , Teva Pharmaceutical Industries Ltd , European Union , Transparency Market Research , Transparency Market Research Inc , Market Research , Atopic Dermatitis Drugs Market , Exclusive Discount , North America , Order Copy , Atopic Dermatitis Drugs Market Report , Canada Toll Free , Atopic Dermatitis , Market Research , Biologic Drugs , Biologic Therapies ,

What 5 cancer leaders are most excited about in 2023

The latest cancer diagnosis, detection and therapies have clinicians excited for what the future may hold. ....

Joanna Sesti , William Tse , Metrohealth Cleveland , Michael Postow , Ken Chaij , Oncology Service Line At Kettering Ohio Health , Division Head Ad , Md Anderson Cancer Center Houston , Barnabas Health West Orange , Executive Director , Oncology Service Line , Head Ad Interim Of Cancer Medicine , Cancer Center , Melanoma Service , Memorial Sloan Kettering Cancer Center , New York City , Thoracic Surgery , West Orange , Robotic Thoracic Surgery , Cooperman Barnabas Medical Center , Director Of Hematology And Oncology , Artificial Intelligence , Cancer Diagnosis , R Linear Accelerators , Biologic Therapies ,

CAR-T cell therapy, recent approvals put precision medicine 'on the horizon' for lupus

The recent success of chimeric antigen receptor-T cell therapy, along with three high-profile FDA approvals, may help make precision medicine a reality in lupus, according to a presenter at the Biologic Therapies Summit.“It is prime time for biologic therapies and the treatment of lupus,” Emily Littlejohn, DO, MPH, of the department of rheumatologic and immunologic disease at the ....

Emily Littlejohn , Shenaz Bagha , Byrob Volansky , Bristol Myers Squibb , Biologic Therapies , Cleveland Clinic ,

'It takes a village' to manage cardiovascular disease in patients with IMIDs

Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit. ....

Shenaz Bagha , Pulkit Chaudhury , Byerich Martin , Biologic Therapies , Cleveland Clinic ,